These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32153798)

  • 41. Impact of Rapid On-demand Molecular Diagnosis of Pediatric Seasonal Influenza on Laboratory Workflow and Testing Costs: A Retrospective Study.
    Brotons P; Nogueras MM; Valls A; Larrauri A; Dominguez A; Launes C; Luaces-Cubells C; Muñoz-Almagro C
    Pediatr Infect Dis J; 2019 Jun; 38(6):559-563. PubMed ID: 31117115
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of a Rapid Point of Care Test for Influenza on Guideline Consistent Care and Antibiotic Use.
    Dale AP; Ebell M; McKay B; Handel A; Forehand R; Dobbin K
    J Am Board Fam Med; 2019; 32(2):226-233. PubMed ID: 30850459
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of the Cobas(®) Influenza A/B Assay for Rapid Pcr-Based Detection of Influenza Compared to Prodesse ProFlu+ and Viral Culture.
    Chen L; Tian Y; Chen S; Liesenfeld O
    Eur J Microbiol Immunol (Bp); 2015 Dec; 5(4):236-45. PubMed ID: 26716012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season.
    Havers F; Thaker S; Clippard JR; Jackson M; McLean HQ; Gaglani M; Monto AS; Zimmerman RK; Jackson L; Petrie JG; Nowalk MP; Moehling KK; Flannery B; Thompson MG; Fry AM
    Clin Infect Dis; 2014 Sep; 59(6):774-82. PubMed ID: 25034419
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of Emergency-Only vs Standard Hemodialysis With Mortality and Health Care Use Among Undocumented Immigrants With End-stage Renal Disease.
    Cervantes L; Tuot D; Raghavan R; Linas S; Zoucha J; Sweeney L; Vangala C; Hull M; Camacho M; Keniston A; McCulloch CE; Grubbs V; Kendrick J; Powe NR
    JAMA Intern Med; 2018 Feb; 178(2):188-195. PubMed ID: 29255898
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Rapid Respiratory Virus Testing on Antibiotic Prescribing Among Children Presenting to the Emergency Department With Acute Respiratory Illness: A Randomized Clinical Trial.
    Rao S; Lamb MM; Moss A; Mistry RD; Grice K; Ahmed W; Santos-Cantu D; Kitchen E; Patel C; Ferrari I; Dominguez SR
    JAMA Netw Open; 2021 Jun; 4(6):e2111836. PubMed ID: 34086034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study.
    Pai AB; Boyd A; Depczynski J; Chavez IM; Khan N; Manley H
    Pharmacotherapy; 2009 Dec; 29(12):1433-40. PubMed ID: 19947803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial.
    Brittain-Long R; Westin J; Olofsson S; Lindh M; Andersson LM
    BMC Med; 2011 Apr; 9():44. PubMed ID: 21521505
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Usefulness of rapid molecular tests in pediatric respiratory tract infections.
    Nardi S; Carolis L; Iannini R; De Sandro MV; Solito G; Calafatti M; Gizzi C
    Ital J Pediatr; 2022 Feb; 48(1):21. PubMed ID: 35115016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].
    Rodríguez A; Alvarez-Rocha L; Sirvent JM; Zaragoza R; Nieto M; Arenzana A; Luque P; Socías L; Martín M; Navarro D; Camarena J; Lorente L; Trefler S; Vidaur L; Solé-Violán J; Barcenilla F; Pobo A; Vallés J; Ferri C; Martín-Loeches I; Díaz E; López D; López-Pueyo MJ; Gordo F; del Nogal F; Marqués A; Tormo S; Fuset MP; Pérez F; Bonastre J; Suberviola B; Navas E; León C; ; ;
    Med Intensiva; 2012 Mar; 36(2):103-37. PubMed ID: 22245450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic performances of the Xpert
    Antoniol S; Fidouh N; Ghazali A; Ichou H; Bouzid D; Kenway P; Choquet C; Visseaux B; Casalino E;
    J Clin Virol; 2018; 99-100():5-9. PubMed ID: 29257982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lab-in-a-tube: Real-time molecular point-of-care diagnostics for influenza A and B using the cobas® Liat® system.
    Melchers WJG; Kuijpers J; Sickler JJ; Rahamat-Langendoen J
    J Med Virol; 2017 Aug; 89(8):1382-1386. PubMed ID: 28213975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of a rapid respiratory panel test on patient outcomes.
    Rogers BB; Shankar P; Jerris RC; Kotzbauer D; Anderson EJ; Watson JR; O'Brien LA; Uwindatwa F; McNamara K; Bost JE
    Arch Pathol Lab Med; 2015 May; 139(5):636-41. PubMed ID: 25152311
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of molecular point-of-care testing on clinical management and in-hospital costs of patients suspected of influenza or RSV infection: a modeling study.
    Rahamat-Langendoen J; Groenewoud H; Kuijpers J; Melchers WJG; van der Wilt GJ
    J Med Virol; 2019 Aug; 91(8):1408-1414. PubMed ID: 30950066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of Scheduled vs Emergency-Only Dialysis With Health Outcomes and Costs in Undocumented Immigrants With End-stage Renal Disease.
    Nguyen OK; Vazquez MA; Charles L; Berger JR; Quiñones H; Fuquay R; Sanders JM; Kapinos KA; Halm EA; Makam AN
    JAMA Intern Med; 2019 Feb; 179(2):175-183. PubMed ID: 30575859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Implementation of Alere i Influenza A & B point of care test for the diagnosis of influenza in an ED.
    Trabattoni E; Le V; Pilmis B; Pean de Ponfilly G; Caisso C; Couzigou C; Vidal B; Mizrahi A; Ganansia O; Le Monnier A; Lina B; Nguyen Van JC
    Am J Emerg Med; 2018 Jun; 36(6):916-921. PubMed ID: 29137903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing the Cobas Liat Influenza A/B and respiratory syncytial virus assay with multiplex nucleic acid testing.
    Gosert R; Naegele K; Hirsch HH
    J Med Virol; 2019 Apr; 91(4):582-587. PubMed ID: 30345524
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting.
    You JHS; Tam LP; Lee NLS
    PLoS One; 2017; 12(7):e0182091. PubMed ID: 28750092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapid influenza diagnostic test use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic.
    Williams LO; Kupka NJ; Schmaltz SP; Barrett S; Uyeki TM; Jernigan DB
    J Clin Virol; 2014 May; 60(1):27-33. PubMed ID: 24630481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.